Advertisement
U.S. markets open in 8 minutes

Chugai Pharmaceutical Co., Ltd. (CHGCY)

Other OTC - Other OTC Delayed Price. Currency in USD
19.56-0.05 (-0.23%)
At close: 04:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/28/2024
Current
9/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
64.35B50.91B46.40B40.35B41.65B
Enterprise Value
60.27B46.45B42.57B36.58B37.54B
Trailing P/E
28.9323.1421.4614.3814.95
Forward P/E
28.5724.6921.4116.8616.56
PEG Ratio (5 yr expected)
9.79N/AN/AN/A15.91
Price/Sales (ttm)
7.636.085.604.274.85
Price/Book (mrq)
6.355.004.723.784.23
Enterprise Value/Revenue
0.050.180.160.120.09
Enterprise Value/EBITDA
0.130.430.370.370.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.48
52-Week Change 360.42%
S&P500 52-Week Change 329.57%
52 Week High 322.61
52 Week Low 311.93
50-Day Moving Average 319.41
200-Day Moving Average 316.64

Share Statistics

Avg Vol (3 month) 387.77k
Avg Vol (10 day) 3111.72k
Shares Outstanding 53.29B
Implied Shares Outstanding 63.29B
Float 8639.37M
% Held by Insiders 10.00%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.29
Forward Annual Dividend Yield 41.47%
Trailing Annual Dividend Rate 380.00
Trailing Annual Dividend Yield 3408.16%
5 Year Average Dividend Yield 41.62
Payout Ratio 438.69%
Dividend Date 3Sep 16, 2019
Ex-Dividend Date 4Jun 29, 2023
Last Split Factor 212:1
Last Split Date 3Jul 06, 2020

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 29.29%
Operating Margin (ttm)44.34%

Management Effectiveness

Return on Assets (ttm)14.44%
Return on Equity (ttm)21.34%

Income Statement

Revenue (ttm)1.11T
Revenue Per Share (ttm)337.76
Quarterly Revenue Growth (yoy)-37.60%
Gross Profit (ttm)N/A
EBITDA 466.09B
Net Income Avi to Common (ttm)325.47B
Diluted EPS (ttm)0.68
Quarterly Earnings Growth (yoy)-11.00%

Balance Sheet

Total Cash (mrq)738.98B
Total Cash Per Share (mrq)449.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.74
Book Value Per Share (mrq)988.01

Cash Flow Statement

Operating Cash Flow (ttm)409.92B
Levered Free Cash Flow (ttm)317.92B